Griseofulvin (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Griseofulvin drug offered from Actavis Pharma, Inc.. This Decreased Mitosis [PE],Microtubule Inhibition [PE],Tubulin Inhibiting Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
NON-PROPRIETARY NAME: | Griseofulvin |
SUBSTANCE NAME: | GRISEOFULVIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Decreased Mitosis [PE],Microtubule Inhibition [PE],Tubulin Inhibiting Agent [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | SUSPENSION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2007-07-26 |
END MARKETING DATE: | 0000-00-00 |
Griseofulvin HUMAN PRESCRIPTION DRUG Details:
Item Description | Griseofulvin from Actavis Pharma, Inc. |
LABELER NAME: | Actavis Pharma, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 125(mg/5mL) |
START MARKETING DATE: | 2007-07-26 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0472-0013_653ba102-a5b8-4fdb-aff7-cfe0550cbdde |
PRODUCT NDC: | 0472-0013 |
APPLICATION NUMBER: | ANDA065394 |
Other GRISEOFULVIN Pharmaceutical Manufacturers / Labelers: